The US Veterinary Vaccines Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.5 billion by 2034, registering a CAGR of 6.2%. This growth trajectory is underpinned by several key factors, including the rising prevalence of infectious diseases among pets and livestock, increased awareness regarding animal health, and advancements in vaccine technology.
The growing pet population in the United States, which reached approximately 90 million dogs and 94 million cats in 2023, has further fueled the demand for veterinary vaccines. According to the American Pet Products Association, pet ownership is on the rise, with 70% of U.S. households owning a pet, thereby increasing the need for preventive healthcare solutions. Additionally, the livestock sector, which contributes significantly to the U.S. economy, is increasingly adopting vaccination programs to enhance animal health and productivity
Get a sample of the report https://www.emergenresearch.co....m/request-free-sampl
Research Report on the US Veterinary Vaccines Market Addresses the Following Key Questions:
• Who are the dominant players of the US Veterinary Vaccines market?
• Which regional ma